Smith Graham & Co. Investment Advisors LP decreased its stake in Kindred Healthcare Inc. (NYSE:KND) by 6.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 613,709 shares of the company’s stock after selling 39,590 shares during the period. Kindred Healthcare comprises about 1.0% of Smith Graham & Co. Investment Advisors LP’s portfolio, making the stock its 26th largest position. Smith Graham & Co. Investment Advisors LP’s holdings in Kindred Healthcare were worth $6,929,000 as of its most recent filing with the SEC.
Other institutional investors have also added to or reduced their stakes in the company. Norges Bank acquired a new position in Kindred Healthcare during the fourth quarter valued at about $8,461,000. Jacobs Levy Equity Management Inc. acquired a new position in Kindred Healthcare during the first quarter valued at about $3,224,000. JPMorgan Chase & Co. boosted its stake in Kindred Healthcare by 50.9% in the first quarter. JPMorgan Chase & Co. now owns 704,631 shares of the company’s stock worth $8,702,000 after buying an additional 237,805 shares in the last quarter. State Street Corp boosted its stake in Kindred Healthcare by 11.3% in the first quarter. State Street Corp now owns 2,120,897 shares of the company’s stock worth $26,191,000 after buying an additional 215,718 shares in the last quarter. Finally, Prudential Financial Inc. boosted its stake in Kindred Healthcare by 110.0% in the first quarter. Prudential Financial Inc. now owns 408,673 shares of the company’s stock worth $5,047,000 after buying an additional 214,100 shares in the last quarter. Institutional investors own 95.61% of the company’s stock.
Shares of Kindred Healthcare Inc. (NYSE:KND) traded up 2.45% during midday trading on Tuesday, reaching $10.47. The company’s stock had a trading volume of 639,555 shares. Kindred Healthcare Inc. has a 12 month low of $7.96 and a 12 month high of $16.42. The stock has a market capitalization of $892.60 million, a PE ratio of 13.53 and a beta of 1.82. The stock’s 50 day moving average is $10.58 and its 200 day moving average is $11.85.
Kindred Healthcare (NYSE:KND) last posted its quarterly earnings results on Friday, August 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.34 by $0.04. The firm had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.85 billion. Kindred Healthcare had a net margin of 0.94% and a return on equity of 6.23%. The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.39 earnings per share. On average, analysts forecast that Kindred Healthcare Inc. will post $0.90 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 2nd. Shareholders of record on Thursday, August 18th were given a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, August 16th. This represents a $0.48 annualized dividend and a yield of 4.58%. Kindred Healthcare’s dividend payout ratio (DPR) is 63.16%.
A number of equities research analysts recently weighed in on the company. Avondale Partners restated a “hold” rating on shares of Kindred Healthcare in a report on Saturday, June 18th. Zacks Investment Research upgraded Kindred Healthcare from a “hold” rating to a “buy” rating and set a $13.00 price target on the stock in a report on Wednesday, June 1st. Mizuho lowered their price target on Kindred Healthcare from $13.50 to $11.00 and set a “neutral” rating on the stock in a report on Wednesday, July 6th. Finally, Bank of America Corp. restated a “sell” rating and issued a $11.00 price target on shares of Kindred Healthcare in a report on Friday, August 5th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $13.57.
In other Kindred Healthcare news, CAO John Joseph Lucchese sold 4,341 shares of Kindred Healthcare stock in a transaction that occurred on Wednesday, June 29th. The shares were sold at an average price of $11.39, for a total value of $49,443.99. Following the transaction, the chief accounting officer now owns 34,130 shares in the company, valued at $388,740.70. The transaction was disclosed in a document filed with the SEC, which is available at this link. 2.25% of the stock is currently owned by company insiders.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc is a healthcare services company. The Company operates through four divisions, including the hospital division, the Kindred at Home division, the Kindred Rehabilitation Services division and the nursing center division. Its divisions represent over six segments, including hospitals, home health services, hospice services, Kindred Hospital Rehabilitation Services, RehabCare and nursing centers.
Want to see what other hedge funds are holding KND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kindred Healthcare Inc. (NYSE:KND).
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.